Peripheral blood lymphocytes genetically modified to express the self/tumor antigen MAGE-A3 induce antitumor immune responses in cancer patients

Dendritic cell (DC) targeting in vivo has recently been shown to confer strong and protective cytotoxic T lymphocyte (CTL)-based immunity in tumor murine models. Our group has recently demonstrated in preclinical models that the infusion of genetically modified lymphocytes (GMLs) expressing the self...

Full description

Saved in:

Bibliographic Details
Published in:	Blood Vol. 113; no. 8; p. 1651
Main Authors:	Fontana, Raffaella, Bregni, Marco, Cipponi, Arcadi, Raccosta, Laura, Rainelli, Cristina, Maggioni, Daniela, Lunghi, Francesca, Ciceri, Fabio, Mukenge, Sylvain, Doglioni, Claudio, Colau, Didier, Coulie, Pierre G, Bordignon, Claudio, Traversari, Catia, Russo, Vincenzo
Format:	Journal Article
Language:	English
Published:	United States 19.02.2009
Subjects:	Adoptive Transfer Animals Antigens, Neoplasm - genetics Antigens, Neoplasm - immunology Cancer Vaccines - administration & dosage Cancer Vaccines - adverse effects Cell Line, Tumor Chlorocebus aethiops COS Cells Genetic Therapy - methods Humans Hypersensitivity, Delayed - immunology Melanoma - immunology Melanoma - pathology Melanoma - therapy Neoplasm Proteins - genetics Neoplasm Proteins - immunology Neoplasm Staging Pilot Projects Skin Neoplasms - immunology Skin Neoplasms - pathology Skin Neoplasms - therapy T-Lymphocytes - cytology T-Lymphocytes - physiology T-Lymphocytes - transplantation Thymidine Kinase - genetics Thymidine Kinase - immunology Transfection
ISSN:	1528-0020, 1528-0020
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!